Title of article
Sunitinib-induced hand-foot syndrome in a Kashmiri male
Author/Authors
Mir, Mohammad H Sheri Kashmir Institute of Medical Sciences - Department of Medical Oncology, India , Rather, Parvaiz A Govt. Medical College - SMHS Hospital - Department of Dermatology, India , Bagdadi, Farhana Sheri Kashmir Institute of Medical Sciences - Department of Internal Medicine, India
From page
180
To page
182
Abstract
Sunitinib belongs to multiple tyrosine kinase inhibitor class of novel targeted therapies used for metastatic solid tumours including renal cell carcinoma. A variety of systemic, as well as, cutaneous side effects due to sunitinib have been described including the hand foot syndrome. We report sunitinib-induced hand foot syndrome in a 65-year-old Kashmiri male and review the literature.
Keywords
Sunitinib , tyrosine kinase inhibitor , renal cell carcinoma , hand , foot syndrome.
Journal title
Journal of Pakistan Association of Dermatologists
Journal title
Journal of Pakistan Association of Dermatologists
Record number
2584326
Link To Document